Paper369806
Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
Brogden RN and 3 others. Drugs, 1979. Cited by 41 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Papers, record 369806. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/369806
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Cefoxitin | Major topic |
| Cephalosporins | Major topic |
| Bacterial Infections | |
| Drug Incompatibility | |
| Drug Stability | |
| Humans | |
| Kinetics |
Source PubMed
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 176,926 | Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/176926 | PubMed |
| 2 | 1,047,087 | Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins. | J Infect Dis | 1976 | https://conductscience.org/library/papers/1047087 | PubMed |
| 3 | 949,182 | Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/949182 | PubMed |
| 4 | 357,399 | Cefoxitin sodium in complicated urinary tract infection. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/357399 | PubMed |
| 5 | 820,241 | In vitro evaluation of cefoxitin and cefamandole. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/820241 | PubMed |
| 6 | 357,385 | Intravenous cefoxitin sodium in the treatment of urinary tract infections. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/357385 | PubMed |
| 7 | 984,809 | Susceptibility of anaerobic bacteria to 23 antimicrobial agents. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984809 | PubMed |
| 8 | 193,441 | Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/193441 | PubMed |
| 9 | 690,021 | Surgical considerations in skin and soft-tissue infections and osteomyelitis treated with cefoxitin sodium. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/690021 | PubMed |
| 10 | 306,221 | Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/306221 | PubMed |
| 11 | 690,025 | Susceptibility of anaerobes to cefoxitin sodium and cephalothin. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/690025 | PubMed |
| 12 | 77,405 | Tissue penetration by cephalosporins. | Lancet | 1978 | https://conductscience.org/library/papers/77405 | PubMed |
| 13 | 20,919,420 | Cefuroxime, an in vitro Comparison with Six Other Cephalosporins. | Proc R Soc Med | 1977 | https://conductscience.org/library/papers/20919420 | PubMed |
| 14 | 690,027 | Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/690027 | PubMed |
| 15 | 319,751 | Lysis if enterobacteria by cefoxitin, cefuroxime, and cephalothin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/319751 | PubMed |
| 16 | 357,381 | Cefoxitin sodium: a clinical and pharmacological study. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/357381 | PubMed |
| 17 | 357,389 | Comparison of cefoxitin sodium and cefazolin. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/357389 | PubMed |
| 18 | 4,843,049 | An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin. | J Antibiot (Tokyo) | 1974 | https://conductscience.org/library/papers/4843049 | PubMed |
| 19 | 308,502 | beta-Lactamases of subspecies of Bacteroides fragilis. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/308502 | PubMed |
| 20 | 357,382 | Clinical experience with cefoxitin sodium in immunologically compromised patients. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/357382 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,246,785 | Physiologically Based Modeling of Cefoxitin, Cefazolin, and Piperacillin Pharmacokinetics in Obese and Lean Rats. | AAPS J | 2025 | https://conductscience.org/library/papers/40246785 | PubMed |
| 39,273,421 | The Application of Green Solvents in the Synthesis of S-Heterocyclic Compounds-A Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273421 | PubMed |
| 38,870,837 | A validated LC-MS/MS method for simultaneous quantitation of piperacillin, cefazolin, and cefoxitin in rat plasma and twelve tissues. | J Pharm Biomed Anal | 2024 | https://conductscience.org/library/papers/38870837 | PubMed |
| 38,651,882 | Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38651882 | PubMed |
| 38,645,489 | Quercetin of huoxuehuayu tongluo decoction and azithromycin combination therapy effectively improves rat tubal factor infertility by inhibiting inflammation. | Iran J Basic Med Sci | 2024 | https://conductscience.org/library/papers/38645489 | PubMed |
| 31,591,127 | Antibiotic prophylaxis with high-dose cefoxitin in bariatric surgery: an observational prospective single center study. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31591127 | PubMed |
| 27,519,493 | Cefminox versus Cefoxitin in Hysterectomy Prophylaxis : Clinical Efficacy and Serum and Tissue Concentrations. | Clin Drug Investig | 1997 | https://conductscience.org/library/papers/27519493 | PubMed |
| 26,612,473 | Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players. | Drugs | 2015 | https://conductscience.org/library/papers/26612473 | PubMed |
| 22,246,211 | Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery. | Eur J Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22246211 | PubMed |
| 11,706,924 | Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics. | Paediatr Drugs | 2001 | https://conductscience.org/library/papers/11706924 | PubMed |
| 7,396,472 | Effect of orally administered probenecid on the pharmacokinetics of cefoxitin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7396472 | PubMed |
| 7,387,820 | Cefoxitin: intravenous pharmacokinetics and intramuscular bioavailability in kwashiorkor. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7387820 | PubMed |
| 6,647,190 | Metronidazole v. cefoxitin in severe appendicitis--a trial to compare a single intraoperative dose of two antibiotics given intravenously. | Postgrad Med J | 1983 | https://conductscience.org/library/papers/6647190 | PubMed |
| 3,588,249 | Influence of protein binding and severity of illness on renal elimination of four cephalosporin drugs in intensive-care patients. | Pharm Weekbl Sci | 1987 | https://conductscience.org/library/papers/3588249 | PubMed |
| 487,957 | Treatment of infections due to nonsporing anaerobes. | Drugs | 1979 | https://conductscience.org/library/papers/487957 | PubMed |
| 37,064 | Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. | Drugs | 1979 | https://conductscience.org/library/papers/37064 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/369806
GET https://conductscience.org/api/papers/v1/369806/references?page=2